Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19.

Carolyn T. Bramante; John B. Buse; David R. Boulware

doi:10.1056/NEJMc2212542

Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19.

Carolyn T. Bramante, John B. Buse, David R. Boulware

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Article number	e65
Journal	New England Journal of Medicine
Volume	387
Issue number	24
DOIs	https://doi.org/10.1056/NEJMc2212542
State	Published - Dec 15 2022

Access

10.1056/NEJMc2212542

OpenUrl availability

Full text

Cite this

@article{f8310ed8f9354c2ba3baa225bbb44ddc,

title = "Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19.",

author = "Bramante, {Carolyn T.} and Buse, {John B.} and Boulware, {David R.}",

year = "2022",

month = dec,

day = "15",

doi = "10.1056/NEJMc2212542",

language = "English (US)",

volume = "387",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "24",

}

TY - JOUR

T1 - Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19.

AU - Bramante, Carolyn T.

AU - Buse, John B.

AU - Boulware, David R.

PY - 2022/12/15

Y1 - 2022/12/15

UR - http://www.scopus.com/inward/record.url?scp=85144585942&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85144585942&partnerID=8YFLogxK

U2 - 10.1056/NEJMc2212542

DO - 10.1056/NEJMc2212542

M3 - Letter

C2 - 36516100

AN - SCOPUS:85144586233

SN - 0028-4793

VL - 387

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 24

M1 - e65

ER -

Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19.

Access

OpenUrl availability

Other files and links

Cite this